Mainstay Medical Holdings announces outcomes from RESTORE clinical trial of ReActiv8 to treat intractable chronic low back pain: Dublin, Ireland Saturday, January 18, 2025, 18:00 ...
Chronic back pain is a prevalent and debilitating condition, significantly impacting quality of life and functional independence. While conventional interventions, including physical therapy and ...
(Nasdaq: ACON), a company specializing in cutting-edge healthcare technology, saw its stock price surge by +6.44%, reaching $0.0479 during Friday’s premarket trading session. The jump follows the ...